Filing Details
- Accession Number:
- 0001181431-10-031766
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-07 13:00:00
- Reporting Period:
- 2010-06-03
- Filing Date:
- 2010-06-07
- Accepted Time:
- 2010-06-07 17:35:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1487371 | Genmark Diagnostics Inc. | GNMK | Surgical & Medical Instruments & Apparatus (3841) | 272053069 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1203763 | Daryl Faulkner | 757 S. Raymond Avenue Pasadena CA 91105 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-06-03 | 16,666 | $6.00 | 16,666 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2010-06-03 | 25,080 | $0.00 | 25,080 | $6.93 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2010-06-03 | 5,785 | $0.00 | 5,785 | $6.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,080 | 2019-09-24 | No | 4 | J | Direct | |
5,785 | 2010-06-03 | 2019-12-22 | No | 4 | J | Direct |
Footnotes
- Received in exchange for options to purchase ordinary shares of Osmetech plc in connection with the reorganization of GenMark Diagnostics, Inc. The reorganization resulted in GenMark becoming the parent company of Osmetech, GenMark's parent company prior to the reorganization, through a scheme of arrangement under Part 26 of the U.K. Companies Act of 2006, but did not alter the proportionate interests of security holders. The number of options issuable pursuant to the reorganization was determined pursuant to an exchange ratio of 230 options to purchase ordinary shares of Osmetech for an option to purchase one share of GenMark common stock.
- 33% of the option shares vest and become exercisable on January 20, 2010, January 20, 2011 and January 20, 2012 respectively.